Companies
Camfil
the Gold Series and Quad Pulse HEPA filtration product lines serve pharmaceutical dust and cleanroom applications, backed by a global ISO-compliant HEPA/ULPA filter manufacturing footprint that recently expanded with a new India facility.
- Country
- Sweden
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| cleanroom-facilities | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | 14.5 billion SEK (net sales in 2025) | damcenter.camfil.com · camfil.com |
| Production site | 30 manufacturing sites worldwide | damcenter.camfil.com · camfil.com |
| Headcount | approximately 6,000 employees worldwide | damcenter.camfil.com · camfil.com |
| Capacity | expanded HEPA and ULPA filter production capacity at its Manesar plant (reported 2026) | emergenresearch.com |
| Certification | ISO-certified manufacturing facilities; products certified to standards including EN 1822, IEST CC 034, ISO 29463, and UL 900 | damcenter.camfil.com · camfil.com |
| Regulatory approval | Quad Pulse Package dust collectors are ATEX category 1 certified and comply with NFPA standards | camfilapc.com · camfil.com |
Independent sources: emergenresearch.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cleanroom HVAC (HEPA/ULPA filtration) | cleanroom-facilities | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.